The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

Investing.com -- Arrowhead Pharmaceuticals (NASDAQ:ARWR) stock surged 16% after the company announced promising interim clinical data for its RNAi-based obesity treatments that showed significant ...

Oatzempic is a viral oat-and-water drink claimed to curb appetite. Here’s what science says about its weight-loss benefits ...

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...

Under a deal with U.S. President Donald Trump, Novo and Lilly also agreed to offer starter doses of their weight-loss pills ...

Investing.com -- Altimmune (NASDAQ:ALT) stock surged 14% Monday after the company announced that its liver disease treatment pemvidutide received Breakthrough Therapy Designation from the U.S. Food ...